US FDA approves generic version of Roche's cancer drug Xeloda
The US Food and Drug Administration (FDA) has approved a generic version of Roche Holding's oral chemotherapy pill, Xeloda (capecitabine).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Food and Drug Administration (FDA) | Oral Cancer | Pharmaceuticals | Xeloda